Nanoform Finland Oyj

HLSE:NANOFH Stock Report

Market Cap: €136.7m

Nanoform Finland Oyj Valuation

Is NANOFH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NANOFH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NANOFH's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NANOFH's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for NANOFH?

Key metric: As NANOFH barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for NANOFH. This is calculated by dividing NANOFH's market cap by their current book value.
What is NANOFH's PB Ratio?
PB Ratio2.1x
Book€65.57m
Market Cap€136.68m

Price to Book Ratio vs Peers

How does NANOFH's PB Ratio compare to its peers?

The above table shows the PB ratio for NANOFH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average7.6x
HRTIS Herantis Pharma Oyj
12.5xn/a€25.5m
PCA PCAS
15.3xn/a€109.9m
MLC Malin
1.3xn/a€158.7m
A038290 Macrogen
1.1x112.2%₩161.2b
NANOFH Nanoform Finland Oyj
2.1x28.4%€136.7m

Price-To-Book vs Peers: NANOFH is good value based on its Price-To-Book Ratio (2.1x) compared to the peer average (7.6x).


Price to Book Ratio vs Industry

How does NANOFH's PB Ratio compare vs other companies in the European Life Sciences Industry?

2 CompaniesPrice / BookEstimated GrowthMarket Cap
NANOFH 2.1xIndustry Avg. 3.2xNo. of Companies7PB0246810+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: NANOFH is good value based on its Price-To-Book Ratio (2.1x) compared to the European Life Sciences industry average (3.2x).


Price to Book Ratio vs Fair Ratio

What is NANOFH's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NANOFH PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio2.1x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate NANOFH's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies